Safety and Efficacy of Low Dose MM120 for ADHD Proof of Concept Trial

NCT05200936 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

ADHD
Attention Deficit Disorder

Interventions

DRUG: MM120
OTHER: Placebo

Sponsor

Definium Therapeutics US, Inc.